Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-κB and conserved lymphokine element 0

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 4, 2004, Pages 555-563

  Bergmann, Martin W ^a   Staples, Karl J ^a   Smith, Susan J ^a   Barnes, Peter J ^a   Newton, Robert ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CONSERVED LYMPHOKINE ELEMENT 0; DEXAMETHASONE; GLUCOCORTICOID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOKINE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; PROLINE DERIVATIVE; TRANSCRIPTION FACTOR AP 1; TRISTETRAPROLIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; RNA TRANSLATION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANTIGENS, SURFACE; BASE SEQUENCE; CELLS, CULTURED; CONSERVED SEQUENCE; DEXAMETHASONE; DNA-BINDING PROTEINS; GLUCOCORTICOIDS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HALF-LIFE; HUMANS; IMMEDIATE-EARLY PROTEINS; LEUKOCYTES, MONONUCLEAR; LYMPHOKINES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PHYTOHEMAGGLUTININS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; RNA-BINDING PROTEINS; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRISTETRAPROLIN;

EID: 1842556193     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0295OC     Document Type: Article

References (35)

1. Chambers. C. A. 2001. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol. 22:217-223.
2. Barnes, P. J. 1999. Therapeutic strategies for allergic diseases. Nature 402 (Suppl.):B31-B38.
3. Razanajaona, D., C. Maroc, M. Lopez, P. Mannoni, and J. Gabert. 1992. Shift from posttranscriptional to predominant transcriptional control of the expression of the GM-CSF gene during activation of human Jurkat cells. Cell Growth Differ. 3:299-305.
4. Shannon, M. F., L. S. Coles, M. A. Vadas, and P. N. Cockerill. 1997. Signals for activation of the GM-CSF promoter and enhancer in T cells. Crit. Rev. Immunol. 17:301-323.
5. Jenkins, F., P. N. Cockerill, D. Bohmann, and M. F. Shannon. 1995. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells. J. Immunol. 155: 1240-1251.
6. Ye, J., X. Zhang, and Z. Dong. 1996. Characterization of the human granulocyte-macrophage colony-stimulating factor gene promoter an AP1 complex and an Sp1-related complex transactivate the promoter activity that is suppressed by a YY1 complex. Mol. Cell. Biol. 16:157-167.
7. Tsuboi, A., K. Sugimoto, J. Yodoi, S. Miyatake, K. Arai, and N. Arai. 1991. A nuclear factor NF-GM2 that interacts with a regulatory region of the GM-CSF gene essential for its induction in responses to T-cell activation: purification from human T-cell leukemia line Jurkat cells and similarity to NF-kappa B. Int. Immunol. 3:807-817.
8. Kaushansky, K., C. O'Rork, S. G. Shoemaker, and J. McCarty. 1996. The regulation of GM-CSF is dependent on a complex interplay of multiple nuclear proteins. Mol. Immunol. 33:461-470.
9. Cockerill, P. N., M. F. Shannon, A. G. Bert, G. R. Ryan, and M. A. Vadas. 1993. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA 90:2466-2470.
10. Cockerill, P. N., A. G. Bert, F. Jenkins, G. R. Ryan, M. F. Shannon, and M. A. Vadas. 1995. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol. Cell. Biol. 15:2071-2079.
11. Cockerill, P. N., A. G. Bert, D. Roberts, and M. A. Vadas. 1999. The human granulocyte-macrophage colony-stimulating factor gene is autonomously regulated in vivo by an inducible tissue-specific enhancer. Proc. Natl. Acad. Sci. USA 96:15097-15102.
12. Newton, R. 2000. Molecular mechanisms of glucocorticoid action: what is important? Thorax 55:603-613.
13. 2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J. Biol. Chem. 273:32312-32321.
14. Walker, G., J. Pfeilschifter, and D. Kunz. 1997. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone: evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J. Biol. Chem. 272:16679-16687.
15. Lasa, M., M. Brook, J. Saklatvala, and A. R. Clark. 2001. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell Biol. 21:771-780.
16. Huang, S., and J. W. Hershey. 1989. Translational initiation factor expression and ribosomal protein gene expression are repressed coordinately but by different mechanisms in murine lymphosarcoma cells treated with glucocorticoids. Mol. Cell. Biol. 9:3679-3684.
17. Kern, J. A., R. J. Lamb, J. C. Reed, R. P. Daniele, and P. C. Nowell. 1988. Dexamethasone inhibition of interleukin 1 beta production by human monocytes: posttranscriptional mechanisms. J. Clin. Invest. 81:237-244.
18. Staples, K. J., M. Bergmann, P. J. Barnes, and R. Newton. 2000. Stimulus-specific inhibition of IL-5 by cAMP-elevating agents and IL-10 reveals differential mechanisms of action. Biochem. Biophys. Res. Commun. 273: 811-815.
19. Staples, K. J., M. W. Bergmann, P. J. Barnes, and R. Newton. 2003. Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone. Immunology 109:527-535.
20. Bergmann, M., P. J. Barnes, and R. Newton. 2000. Molecular regulation of granulocyte-macrophage colony-stimulating factor in human lung epithelial cells by IL-1, IL-4 and IL-13 involves both transcriptional and post-transcriptional mechanisms. Am. J. Respir. Cell Mol. Biol. 22:582-589.
21. Nasuhara, Y., I. M. Adcock, M. Catley, P. J. Barnes, and R. Newton. 1999. Differential IKK activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells: evidence for additional regulatory steps in kappaB-dependent transcription. J. Biol. Chem. 274:19965-19972.
22. Stratowa, C., H. Machat, E. Burger, A. Himmler, R. Schafer, W. Spevak, U. Weyer, M. Wiche-Castanon, and A. P. Czernilofsky. 1995. Functional characterization of the human neurokinin receptors NK1, NK2, and NK3 based on a cellular assay system. J. Recept. Signal Transduct. Res. 15: 617-630.
23. Mahtani, K. R., M. Brook, J. L. Dean, G. Sully, J. Saklatvala, and A. R. Clark. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21:6461-6469.
24. Raghavan, A., R. L. Robison, J. McNabb, C. R. Miller, D. A. Williams, and P. R. Bohjanen. 2001. HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J. Biol. Chem. 276:47958-47965.
25. Fischer, G. F., W. Holter, O. Majdic, E. J. Cragoe, Jr., and W. Knapp. 1988. T cell stimulation via CD2 molecules is regularly accompanied by an increase in cytoplasmic pH. Different effects of lectins and CD3 antibodies. J. Immunol. 141:404-409.
26. Masuda, E. S., H. Tokumitsu, A. Tsuboi, J. Shlomai, P. Hung, K. Arai, and N. Arai. 1993. The granulocyte-macrophage colony-stimulating factor promoter cis-acting element CLE0 mediates induction signals in T cells and is recognized by factors related to AP1 and NFAT. Mol. Cell. Biol. 13:7399-7407.
27. Smith, P. J., D. J. Cousins, Y. K. Jee, D. Z. Staynov, T. H. Lee, and P. Lavender. 2001. Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite nf-at/activator protein-1 elements. J. Immunol. 167:2502-2510.
28. De-Bosscher, K., M. L. Schmitz, W. Vanden-Berghe, S. Plaisance, W. Fiers, and G. Haegeman. 1997. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA 94:13504-13509.
29. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
30. Scheinman, R. I., A. Gualberto, C. M. Jewell, J. A. Cidlowski, and A. S. Baldwin, Jr. 1995. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15:543-953.
31. Heck, S., K. Bender, M. Kullman, M. Gottlicher, P. Herrlich, and A. C. B. Cato. 1997. IkBα-independent downregulation of NF-kB activity by glucocorticoid receptor. EMBO J. 16:4698-4707.
32. Zenklusen, D., and F. Stutz. 2001. Nuclear export of mRNA. FEBS Lett 498:150-156.
33. Wilusz, C. J., M. Wormington, and S. W. Peltz. 2001. The cap-to-tail guide to mRNA turnover. Nat. Rev. Mol. Cell Biol. 2:237-246.
34. Swantek, J. L., M. H. Cobb, and T. D. Geppert. 1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/ SAPK. Mol. Cell. Biol. 17:6274-6282.
35. Krane, I. M., E. R. Spindel, and W. W. Chin. 1991. Thyroid hormone decreases the stability and the poly(A) tract length of rat thyrotropin beta-subunit messenger RNA. Mol. Endocrinol. 5:469-475.